Why it's a key strategy to optimize biologic therapies and improve outcomes in pediatric IBD
An integrated approach to care
Life-changing gene therapy is currently under FDA review
How evolving medical therapies and more precise patient selection are reshaping the role of intestinal transplantation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic specialist discusses the new clinical practice guideline
Study found lower rates of nausea, vomiting and healthcare use through 12 months of follow-up
What to know about the condition, and 5 strategies to improve patient care
Biologic therapy and advances in monitoring may ease treatment and follow-up for families
Minimally invasive options for conditions that may otherwise require surgery or referral to adult centers
Study utilizes prospective data from the RISK cohort
Advertisement
Advertisement